The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

The RSV vaccine isn't needed annually like the flu vaccine ... In adults, the most frequently reported side effects have been ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD.

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Moderna reported a surprising third-quarter profit on Thursday, driven by cost reductions and stronger-than-expected sales of ...

Rachel Spiers, Immunisation and Vaccination Programme Manager at the PHA, said if you are at risk and in one of the eligible ...

This summer, the FDA approved Moderna's mRESVIA RSV vaccine for adults ... In adults, the most frequently reported side effects have been soreness at the injection site, muscle pain, fatigue ...